Evidence map›Paper›PMID 31725198›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2019

Combinatorial Delivery of miRNA-Nanoparticle Conjugates in Human Adipose Stem Cells for Amplified Osteogenesis.

Mohammad Abu-Laban, Prakash Hamal, Julien H Arrizabalaga, Anoosha Forghani, Asela S Dikkumbura, Raju R Kumal, Louis H Haber, Daniel J Hayes

Open access · greenAbstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Bioprinting of miRNA-Induced Spheroids for Vascularized, Heterocellular Bone Regeneration.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. RNA therapeutics in the clinic.Bioengineering & translational medicine · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. MicroRNA-loaded biomaterials for osteogenesis.Frontiers in bioengineering and biotechnology · 2022
    Review
  15. Growth Dynamics of Colloidal Silver-Gold Core-Shell Nanoparticles Studied byThe journal of physical chemistry. C, Nanomaterials and interfaces · 2021
    Article
  16. Article
  17. Emerging strategies in reprogramming and enhancing the fate of mesenchymal stem cells for bone and cartilage tissue engineering.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mohammad Abu-LabanThe Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.ORCID 0000-0002-6894-3035
Prakash HamalThe Department of Chemistry, Louisiana State University, Baton Rouge, LA, 70803, USA.
Julien H ArrizabalagaThe Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.
Anoosha ForghaniThe Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.
Asela S DikkumburaThe Department of Chemistry, Louisiana State University, Baton Rouge, LA, 70803, USA.
Raju R KumalJohn and Willie Leone Family Department of Energy and Mineral Engineering, Pennsylvania State University, University Park, PA, 16802, USA.
Louis H HaberThe Department of Chemistry, Louisiana State University, Baton Rouge, LA, 70803, USA.
Daniel J HayesThe Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA, 16802, USA.
Pennsylvania State University · USLouisiana State University · US

Funding

Spatiotemporal Modulation of Osteogenesis in a 3-D Stromal/Stem Cell ModelR01DE024790 · NIDCR · PENNSYLVANIA STATE UNIVERSITY, THE · PI HAYES, DANIEL J. · 2015 to 2019
$1.7M
NIDCR NIH HHS R01 DE024790NIH HHS RDE024790A
6 · The paper itself

Abstract

It is becoming more apparent in tissue engineering applications that fine temporal control of multiple therapeutics is desirable to modulate progenitor cell fate and function. Herein, the independent temporal control of the co-delivery of miR-148b and miR-21 mimic plasmonic nanoparticle conjugates to induce osteogenic differentiation of human adipose stem cells (hASCs), in a de novo fashion, is described. By applying a thermally labile retro-Diels-Alder caging and linkage chemistry, these miRNAs can be triggered to de-cage serially with discrete control of activation times. The method relies on illumination of the nanoparticles at their resonant wavelengths to generate sufficient local heating and trigger the untethering of the Diels-Alder cycloadduct. Characterization of the photothermal release using fluorophore-tagged miRNA mimics in vitro is carried out with fluorescence measurements, second harmonic generation, and confocal imaging. Osteogenesis of hASCs from the sequential co-delivery of miR-21 and miR-148b mimics is assessed using xylenol orange and alizarin red staining of deposited minerals, and quantitative polymerase chain reaction for gene expression of osteogenic markers. The results demonstrate that sequential miRNA mimic activation results in upregulation of osteogenic markers and mineralization relative to miR-148b alone, and co-activation of miR-148b and miR-21 at the same time.

Indexed as

OsteogenesisAdipose TissueCell CountCells, CulturedGoldHumansMetal NanoparticlesMicroRNAsSilverSOXB1 Transcription FactorsSpectrophotometry, UltravioletSpectrum Analysis, RamanStem CellsTransfectionGoldMicroRNAsSilverSOXB1 Transcription FactorsgoldmicroRNAnanoparticlesretro-Diels-Aldersequentialsilver

Identifiers

PMID31725198
PMCPMC8530457
OpenAlexW2985775924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.